Pfizer's CEO, Jeffrey Kindler has received the 2010 Catalyst Award, the Glaucoma Research Foundation's highest honour, acknowledging his role in sustaining innovative research and education.

Related Content:

Articles

DMO study shows robust efficacy of intravitreal dexamethasone implant

The quest for topical treatments for the posterior segment

Use of virtual reality training in amblyopia